U.S. Markets closed

What's next for this slow-moving Peninsula biotech IPO?

Ron Leuty
What's next for this slow-moving Peninsula biotech IPO?

The company filed in late September for a $75 million initial public offering but has yet to release any more information, even as a key partnership hits major milestones.